Jan Remsik, PhD PharmD

Jan Remsik, PhD, PharmD Memorial Sloan Kettering Cancer Center Leptomeningeal metastasis (LM), or the spread of tumor cells into the cerebrospinal fluid, is an increasingly common complication of cancer that results in rapid neurologic disability and death. Colonization of leptomeningeal space by cancer cells can take years or even decades after primary cancer diagnosis. The

Jan Remsik, PhD PharmD Read More »

Palbociclib tolerability in brain metastases

Palbociclib Shows Activity, Tolerability in Patients with Brain Metastases Harboring CDK Pathway Alterations Dylann Cohn-Emery Published Online: 5:00 PM, Mon November 25, 2019 The 2019 Society for NeuroOncology’s Annual Meeting (SNO) focused on innovation to overcome tumor resistance. The meeting was held late November in Phoenix, Arizona. An interim analysis of the phase II study

Palbociclib tolerability in brain metastases Read More »

New findings on RNA processing

Layman’s road map to recent research publication By SANDY MANISCALCO Following is an introduction to a recent publication in Cell Reports, describing findings on RNA processing dysregulation in breast cancer, funded in part by the Terri Brodeur Breast Cancer Foundation. 2013 grant recipient, Olga Anczukow, PhD, explained this research with the support of the Terri

New findings on RNA processing Read More »

Scroll to Top
Skip to content